← Current compounder rows

Current NDC auxiliary source row compounder:3138

This page is keyed by dataset, FDA.report source record ID, and physical source row number. Empty values are shown rather than omitted.

Complete normalized row#

Record Source
ndc_compounder_zip
Product Ndc Raw
73013-2001
Product Ndc
73013-2001
Product Ndc Digits
730132001
Product Type Name
HUMAN COMPOUNDED DRUG
Proprietary Name
Ketamine Hydrochloride 50mg/mL
Proprietary Name Suffix
[empty]
Nonproprietary Name
Ketamine HCl
Dosage Form Name
INJECTION, SOLUTION
Route Name
INTRAMUSCULAR; INTRAVENOUS
Marketing Category Name
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
Labeler Name
OurPharma LLC
Establishment Name
OurPharma LLC
Establishment Fei
[empty]
Substance Name
KETAMINE HYDROCHLORIDE
Active Ingredients Info
50 mg/1 mL
History Active Ingredients Raw
KETAMINE HYDROCHLORIDE
History Active Ingredients Info Raw
50 mg/1 mL
History Dosage Raw
INJECTION, SOLUTION
Dea Schedule
CIII
Package Ndc Raw
73013-2001-3
Package Ndc
73013-2001-3
Package Ndc Digits
7301320013
Package Ndc11
73013200103
Package Description
1 mL in 1 SYRINGE (73013-2001-3)
Reporting Period Raw
2024-2
Reporting Period
2024-2
Normalization Status
valid
Source Url
https://www.accessdata.fda.gov/cder/compounders_ndc_directory.zip
Source Archive
compounders_ndc_directory.zip
Source File
compounders_ndc_directory.txt
Source Date
2026-09-18
Source Last Modified
Fri, 18 Sep 2026 15:17:23 GMT
Source Archive Sha256
222f6800f79cb1a0fa79431b7226bd6b34899999dbf086af51004a96774ada98
Source Member Sha256
f8d9743e5616579a34d614887e86a53913efa0a63d3138d59d2f87cbb4d0cc17
Source Record Id
compounder:3138
Source Row Number
3138
Source Row Hash
863b6a5a3ab8a542fcce313d241d711e101ad83e90a060d2da04ef98cc61b580
Import Run Id
20261116T204628Z
Loaded At
2026-11-16 20:58:00

Exact raw FDA source fields#

{
    "ROUTENAME": "INTRAMUSCULAR; INTRAVENOUS",
    "PRODUCTNDC": "73013-2001",
    "DEASCHEDULE": "CIII",
    "LABELERNAME": "OurPharma LLC",
    "SUBSTANCENAME": "KETAMINE HYDROCHLORIDE",
    "DOSAGEFORMNAME": "INJECTION, SOLUTION",
    "NDCPACKAGECODE": "73013-2001-3",
    "PRODUCTTYPENAME": "HUMAN COMPOUNDED DRUG",
    "PROPRIETARYNAME": "Ketamine Hydrochloride 50mg/mL",
    "REPORTINGPERIOD": "2024-2",
    "NONPROPRIETARYNAME": "Ketamine HCl",
    "PACKAGEDESCRIPTION": "1 mL in 1 SYRINGE (73013-2001-3) ",
    "ACTIVEINGREDIENTSINFO": "50 mg/1 mL",
    "MARKETINGCATEGORYNAME": "OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)",
    "PROPRIETARYNAMESUFFIX": ""
}

Normalization notes#

[]

Current status projection#

Dataset
compounder
Record Source
ndc_compounder_zip
Source Record Id
compounder:3138
Source Row Number
3138
Status Scope
package
Lookup Ndc
73013-2001-3
Lookup Ndc Digits
7301320013
Product Ndc
73013-2001
Product Ndc Digits
730132001
Package Ndc
73013-2001-3
Package Ndc Digits
7301320013
Package Ndc11
73013200103
Product Id
[empty]
Status Code
COMPOUNDER
Status Label
Outsourcing facility compounded drug report
Reporting Period Raw
2024-2
Reporting Period
2024-2
Source Table
fda_ndc_aux_compounder
Source File
compounders_ndc_directory.txt
Source Date
2026-09-18
Source Row Hash
863b6a5a3ab8a542fcce313d241d711e101ad83e90a060d2da04ef98cc61b580
Import Run Id
20261116T204628Z
Loaded At
2026-11-16 20:58:00